Results 131 to 140 of about 116,920 (292)
Single circulating tumor cells (sCTCs) from high‐grade serous ovarian cancer patients were enriched, imaged, and genomically profiled using WGA and NGS at different time points during treatment. sCTCs revealed enrichment of alterations in Chromosomes 2, 7, and 12 as well as persistent or emerging oncogenic CNAs, supporting sCTC identity.
Carolin Salmon +9 more
wiley +1 more source
Targeting p38α in cancer: challenges, opportunities, and emerging strategies
p38α normally regulates cellular stress responses and homeostasis and suppresses malignant transformation. In cancer, however, p38α is co‐opted to drive context‐dependent proliferation and dissemination. p38α also supports key functions in cells of the tumor microenvironment, including fibroblasts, myeloid cells, and T lymphocytes.
Angel R. Nebreda
wiley +1 more source
Dynamic pricing scheme for energy balancing in microgrid using an intelligent system. [PDF]
Balakumar I, Vaithilingam C.
europepmc +1 more source
Improving the H_k-Bound on the Price of Stability in Undirected Shapley Network Design Games [PDF]
Yann Disser +3 more
openalex +1 more source
STABILITY AND DIRECTION OF HOPF BIFURCATION OF A MODEL WITH R&D SPILLOVERS AND PRICE COMPETITION
Luca Guerrini
openalex +1 more source
Tumour–host interactions in Drosophila: mechanisms in the tumour micro‐ and macroenvironment
This review examines how tumour–host crosstalk takes place at multiple levels of biological organisation, from local cell competition and immune crosstalk to organism‐wide metabolic and physiological collapse. Here, we integrate findings from Drosophila melanogaster studies that reveal conserved mechanisms through which tumours hijack host systems to ...
José Teles‐Reis, Tor Erik Rusten
wiley +1 more source
Boosting Food System Stability Through Technological Progress in Price and Supply Dynamics. [PDF]
Doran NM.
europepmc +1 more source
The German Constitutional Court Decides Price Stability May Not Be Worth Its Price [PDF]
Gareth Davies
openalex +1 more source
Cotargeting TREM2 and IL2 pathways triggers multipronged anticancer immunity
Von Locquenghien et al. report that MiTE‐144, a triggering receptor expressed on myeloid cells 2 (TREM2) blocking antibody fused to interleukin‐2 (IL2) variant with tumour microenvironment restricted activation, demonstrates superior anticancer efficiency in a preclinical setting.
Isaure Vanmeerbeek +2 more
wiley +1 more source

